OPN is overexpressed in various types of cancer, including pancreatic cancer (Koopmann et al., 2004), and OPN treatment has been reported to induce malignant phenotypes in PCCs (Kolb et al., 2005). The gene discussed is SPP1; the disease is familial pancreatic carcinoma.